Baraclude (Entecavir)

Entecavir · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Baraclude (Entecavir), covering 2017-01-10 to 2017-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma [Phase 4]

See pricing